000 01924 a2200505 4500
005 20250513220141.0
264 0 _c20000920
008 200009s 0 0 eng d
022 _a0270-4137
024 7 _a10.1002/1097-0045(20000915)45:1<51::aid-pros6>3.0.co;2-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _adel Vecchio, M T
245 0 0 _aMacrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes.
_h[electronic resource]
260 _bThe Prostate
_cSep 2000
300 _a51-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAged
650 0 4 _aAndrogen Antagonists
_xadministration & dosage
650 0 4 _aAndrogens
_xphysiology
650 0 4 _aAntineoplastic Agents, Hormonal
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBiopsy, Needle
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aFlutamide
_xadministration & dosage
650 0 4 _aGonadotropin-Releasing Hormone
_xagonists
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMacrophage Migration-Inhibitory Factors
_xbiosynthesis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoadjuvant Therapy
650 0 4 _aPrognosis
650 0 4 _aProstate
_xmetabolism
650 0 4 _aProstatic Intraepithelial Neoplasia
_xdrug therapy
650 0 4 _aProstatic Neoplasms
_xdrug therapy
700 1 _aTripodi, S A
700 1 _aArcuri, F
700 1 _aPergola, L
700 1 _aHako, L
700 1 _aVatti, R
700 1 _aCintorino, M
773 0 _tThe Prostate
_gvol. 45
_gno. 1
_gp. 51-7
856 4 0 _uhttps://doi.org/10.1002/1097-0045(20000915)45:1<51::aid-pros6>3.0.co;2-9
_zAvailable from publisher's website
999 _c10908390
_d10908390